CD70-Driven Chronic Immune Activation Is Protective against Atherosclerosis

Ronald W. van Olffen, Alex M. de Bruin, Mariska Vos, Anna D. Staniszewska, Jörg Hamann, René A. W. van Lier, Carlie J. M. de Vries, Martijn A. Nolte

Research output: Contribution to journalArticleAcademicpeer-review

20 Citations (Scopus)

Abstract

Chronic infection and inflammation are strongly associated with the development of atherosclerosis. To investigate whether chronic inflammation in the absence of an infectious cause also predisposes to the development of atherosclerosis, we used a mouse model in which sterile inflammation is driven by enhanced costimulation. Constitutive triggering of CD27 on T cells through overexpression of CD70 on B cells increases the numbers of IFN gamma-producing effector T cells, which reduces the numbers of B cells. However, despite these pro-atherogenic features, we found that CD70-transgenic (CD70TG) mice on an ApoE*3-Leiden background were strongly protected against the induction of atherosclerotic lesions, with a normal increase in serum cholesterol level and the absence of atheroprotective antibodies. We found that circulating monocytes in CD70TG mice were activated and increased in numbers, in particular the pool of inflammatory (Ly6C(+)) monocytes. Importantly, monocytes from CD70TG mice had no defects in phagocytosis nor in TNF alpha production, but they were more prone to apoptosis, which was IFN gamma-dependent. These data indicate that sterile pro-inflammatory conditions can be protective against atherosclerosis development, possibly due to a reduced viability of circulating monocytes. This unexpected outcome provides a new insight into the consequences of costimulatory signals and their impact on innate immunity. Copyright (C) 2010 S. Karger AG, Basel
Original languageEnglish
Pages (from-to)344-352
JournalJournal of innate immunity
Volume2
Issue number4
DOIs
Publication statusPublished - 2010

Cite this